ArticleNature communications2022

Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer.

Yuji Kubota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.